Related Experiment Video
Updated: Feb 24, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Bronchiolitis in Infants and Children
Alexandra Schaller1, Carl S Galloway2,1
1Sanford Children's Hospital, Sioux Falls, South Dakota.
Insights
Bronchiolitis is a common infant illness, often caused by respiratory syncytial virus. Management is supportive, with prevention focusing on hygiene, breastfeeding, and avoiding smoke exposure.
Area of Science:
- Pediatrics
- Infectious Diseases
- Respiratory Medicine
Background:
- Bronchiolitis is a frequent pediatric illness and a leading cause of infant hospitalization in the U.S.
- Respiratory syncytial virus is the most common viral cause.
- Diagnosis relies on clinical evaluation, with limited use for ancillary tests.
Purpose of the Study:
- To summarize current understanding and management of bronchiolitis in infants and children.
- To highlight evidence-based clinical practice guidelines for diagnosis, treatment, and prevention.
Main Methods:
- Clinical diagnosis based on history and physical examination.
- Supportive care as the primary management strategy.
- Review of preventive measures and specific prophylaxis recommendations.
Main Results:
- Medications show limited utility in treating bronchiolitis.
- Preventive strategies include hand hygiene, breastfeeding, and smoke avoidance.
- Palivizumab prophylaxis is indicated for high-risk infants.
Conclusions:
- Bronchiolitis management is primarily supportive.
- Prevention and appropriate prophylaxis are key for vulnerable populations.
- Recent guidelines from the American Academy of Pediatrics offer comprehensive recommendations.
Abstract:
Bronchiolitis is among the most common illnesses in infants and children, and is the most common cause for hospitalization in infants in the U.S. This illness can be caused by many viruses, most commonly respiratory syncytial virus. It is diagnosed clinically by history and physical exam findings, with a narrow role for ancillary testing. Management is supportive, with medications demonstrating limited utility in multiple studies. Preventive measures include hand hygiene, breastfeeding, avoiding tobacco smoke exposure, and isolation precautions for hospitalized patients. Palivizumab prophylaxis is recommended for infants with qualifying high risk conditions. Recent evidence-based clinical practice guidelines have been published by the American Academy of Pediatrics to guide diagnosis, treatment, and prevention of bronchiolitis.
Related Concept Videos
Pulmonary Cycle: Exhalation
The Bronchial Tree
The trachea, commonly known as the windpipe, is a tube that connects the larynx (voice box) to the bronchi. At a point called the carina, it bifurcates into two primary bronchi. The right primary bronchus is wider, shorter, and more vertical than the left primary...
Breathing
Asthma-I: Introduction
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

